Skip to content
18 November · 06:30 UTCFollow GSK by emailFollow

GSK · story · 18 November

GSK presents growth plan at Jefferies healthcare conference

GSK · 7 headlines from 6 outlets, on 18 November 2026.

The story

+0.7neutral
Headlines7
Outlets6
Days118 November

Coverage of GSK's conference presentation covers its 2031 sales ambition, savings, Phase III starts and the HIV patent cliff.

The story's tone is the average of its headlines' own scores. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.

How each outlet covered it · 6 outlets

Every outlet, by impact on the tone

Average tone of each outlet's headlines in this story, −10 to +10. Impact = headlines × strength of tone.

Source: MarketFrame news analysis

Every outlet, by impact on the tone. Average tone of each outlet's headlines in this story, −10 to +10. Impact = headlines × strength of tone. Source: MarketFrame news analysis
outletAverage tone
TradingView3.8
Investing.com India5.8
Traders Union−5.0
AD HOC NEWS−5.0
Yahoo Finance3.3
Investing.com−1.7
OutletHeadlinesAverage tone
TradingView2+3.8
Investing.com India1+5.8
Traders Union1−5.0
AD HOC NEWS1−5.0
Yahoo Finance1+3.3
Investing.com1−1.7

One or two headlines is not a lean: read these as how this story was told, not as a verdict on the outlet.

Day by day · 1 day, strongest headlines first

Wednesday 18 November 20267 headlines · Coverage of GSK's conference presentation covers its 2031 sales ambition, savings, Phase III starts and the HIV patent cliff.+0.7
ToneWhat the article reported, and why it scored that waySource
+8.3Cost savings and pipeline starts underpin ambitious long-term sales goal.TradingView (opens the article) ↗
+5.8Management says growth plan is accelerating.Investing.com India (opens the article) ↗
−5.0Job cuts and restructuring raise pressure on shares.Traders Union (opens the article) ↗
−5.0Concern over expiring patents despite oncology plans.AD HOC NEWS (opens the article) ↗
+3.3Finance chief relies on oncology to offset forecast shortfall.Yahoo Finance (opens the article) ↗
−1.7Growth plan discussed alongside patent expiry challenge.Investing.com (opens the article) ↗
−0.8Ambitious sales target tempered by HIV patent expiry concerns.TradingView (opens the article) ↗

Follow by email

A short, free morning email on how the news treated GSK: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.

How it works. Every morning an AI model reads the UK business news about each FTSE 100 company and scores how good or bad it is for the company, from −10 to +10. Pages update by about 07:45 UK time.

Not investment advice. MarketFrame rates the tone of news coverage. It is general information, not a recommendation to buy or sell anything. The scores are not share-price data or forecasts: a good score doesn't mean a share will rise, and a bad one doesn't mean it will fall.

Data to 06:30 UTC, 18 November · 867 headlines · 94 companiesMade by Adapt Progress Evolve Limited, a UK company · Privacy · Terms · Who we are · RSS · API · llms.txt